aTyr Pharma | LIFE - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
Alterity Therapeutics Limited AUD -6.26M 1.52M 2025-12
Ardelyx USD -37.6M 37.2M 2026-03
aTyr Pharma USD -153K 25.59M 2026-03
Biogen USD 647.3M 269.6M 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Cipla INR 10.82B 3.33B 2026-06
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD -7.66M 64.51M 2026-03
CSL USD 2.61B 1.21B 2025-12
Curis USD -24.2M 43.56M 2026-03
GlaxoSmithKline GBP 2.68B 532M 2026-06
Grifols EUR 257.85M 190.87M 2024-12
Lakefront Biotherapeutics EUR 13.96M 769.2M 2026-03
Novartis USD 4.27B 430M 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
United Therapeutics USD 372.7M 54.4M 2026-06